Original Investigation
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria
Reineke Soegiharto, MD; Mehran Alizadeh Aghdam, MD, PhD; Jennifer Astrup Sørensen, MD; Esmee van Lindonk, BSc; Ferhan Bulut Demir, MD; Nasser Mohammad Porras, MD; Yoshimi Matsuo, MD; Lea Kiefer, MD, PhD; André C. Knulst, MD, PhD; Marcus Maurer, MD, PhD; Carla Ritchie, MD; Michael Rudenko, MD, PhD; Emek Kocatürk, MD, PhD; Roberta F. J. Criado, MD, PhD; Stamatis Gregoriou, MD, PhD; Tatjana Bobylev, MD; Andreas Kleinheinz, MD, PhD; Shunsuke Takahagi, MD, PhD; Michihiro Hide, MD, PhD; Ana M. Giménez-Arnau, MD, PhD; Andaç Salman, MD, PhD; Rabia O. Kara, MD, PhD; Bahar Sevimli Dikicier, MD, PhD; Martijn B. A. van Doorn, MD, PhD; Simon F. Thomsen, MD, PhD; Juul M. P. A. van den Reek, MD, PhD; Heike Röckmann, MD, PhD
JAMA Dermatology